NCT06178874 is a NA clinical trial of Insulin Glargine in Glycemic Control, sponsored by Ain Shams University.

Who is sponsoring NCT06178874?

NCT06178874 is sponsored by Ain Shams University.

What drugs are being tested in NCT06178874?

Interventions in NCT06178874: Insulin Glargine, Insulin Degludec, Insulin regular.

What condition does NCT06178874 study?

NCT06178874 studies Glycemic Control, Insulin, Critical Illness.

Is NCT06178874 still recruiting?

NCT06178874 is currently completed. Last updated 5 August 2024.

Last reviewed 2024-08-05 · How we verify

NCT06178874

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia

Completed NA Last updated 5 August 2024

What this trial tests

NA trial testing Insulin Glargine in Glycemic Control in 90 participants. Completed in 1 June 2024.

Timeline

1 December 2023

Primary endpoint
25 May 2024

1 June 2024

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	90
Start date	1 December 2023
Primary completion	25 May 2024
Estimated completion	1 June 2024
Sites	1 location across Egypt

Drugs / interventions tested

Insulin Glargine (INSULIN GLARGINE) — full drug profile →
Insulin Degludec (INSULIN DEGLUDEC) — full drug profile →
Insulin regular — full drug profile →

Conditions studied

Glycemic Control — all drugs for Glycemic Control →
Insulin — all drugs for Insulin →
Critical Illness — all drugs for Critical Illness →

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Glycemic Control or Insulin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The role of ultralong insulin in the control of the blood glucose level in diabetic patients is well known, the current study will discuss the role of ultralong insulin in controlling of hyperglycaemia in critical illness defined as failure or impending failure of an organ

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness Hyperglycemia.
El Sherif IM, Haggag AM, Abbas MH, Kamel WY. · · 2025 · PMID 39802245 · DOI 10.5005/jp-journals-10071-24842

Verify or expand the search:

Other trials of Insulin Glargine

Trials testing the same drug.

NCT06370715 — A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India · Phase 4 · completed
NCT05803421 — A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and O · Phase 3 · completed
NCT05699408 — To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequate · Phase 3 · completed
NCT05702073 — To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With · Phase 3 · completed
NCT05614089 — Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings · Phase 4 · completed

Other recruiting trials for Glycemic Control

Currently open trials in the same condition.

NCT06817252 — How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes · NA · recruiting
NCT06810596 — Comparing Efficacy Between Two Protocols of Intravenous Insulin Infusion for Diabetic Adults in ICU · NA · recruiting
NCT05644717 — Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD · Phase 4 · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06178874 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 5 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06178874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing